While the responsiveness of human CFs to TGFβ or the ability of ACLYi to reverse the phenotype shows some degree of variability between donor hearts, the expression of the prototypical marker of a myofibroblast, αSMA, was conserved across all HF etiologies. This evidence concerns the gene ACTA1 and hydrops fetalis.